WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert I. BlumPresident CEO2025-04-295,000$40.96
$204.80kSell
Fady Ibraham MalikEVP Research Development2025-04-222,000$10.60
$21.20kBuy
Fady Ibraham MalikEVP Research Development2025-04-222,000$38.11
$76.22kSell
Wendall WierengaDirector2025-04-2120,000$38.46
$769.20kSell
Wendall WierengaDirector2025-04-2120,000$6.21
$124.20kBuy
Nancy WysenskiDirector2025-04-15162$38.56
$6.25kBuy
John T. HendersonDirector2025-04-15551$38.56
$21.25kBuy
John T. HendersonDirector2025-04-1520,000$6.21
$124.20kBuy
John T. HendersonDirector2025-04-153,190$38.66
$123.33kSell
Edward M. Md KayeDirector2025-04-15324$38.56
$12.49kBuy

1 of 16

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc13.06%15,469,378$637.65MInstitution
Vanguard Group Inc10.06%11,915,821$491.17MInstitution
Fmr LLC9.12%10,794,686$444.96MInstitution
T Rowe Price Investment Management Inc9.08%10,752,123$443.20MInstitution
Michael Schmertzler8.22%9,730,131$401.08MInsider
Wellington Management Group LLP6.66%7,888,697$325.17MInstitution
State Street Corp5.21%6,167,340$254.22MInstitution
Eastern Capital Ltd2.44%2,883,845$118.87MInsider
Geode Capital Management LLC2.40%2,841,338$117.12MInstitution
Rtw Investments LP2.30%2,721,158$112.17MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK89.65%10.35%Net SellingNet Selling
KRYS78.59%21.41%Net SellingNet Selling
IONS96.63%3.37%Net SellingNet Selling
PCVX87.56%12.44%Net SellingNet Buying
AXSM70.18%29.82%Net BuyingNet Buying
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 111.18% institutional shareholders, 12.83% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 8.22% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $401.76M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.